Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 189, 106637
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Multidimensional Index and Staging System for Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2012
- Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The SF-36 and SGRQ: Validity and first look at minimum important differences in IPFRespiratory Medicine, 2010
- Development and validation of a cough and sputum assessment questionnaireRespiratory Medicine, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed TomographyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- The St George's Respiratory QuestionnaireRespiratory Medicine, 1991